I agree but part of my personal assessment of derisked is also what I pay. I have a significant old holding purchased at very low prices but I also bought around 1mill shares between .20 and .45c so my derisking involves selling down at those higher prices for the interim while the price was quite wobbly and generating some capital losses and going back in again. So it’s a holistic view for me in relation to the company performance but also the various tranches purchased. Onwards!!
Ann: Imugene PD1-Vaxx Immunotherapy Patent Granted in the US, page-80
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |